Clinical Trial Update: A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase I pilot trial compares two radiopharmaceuticals, 123I MIP 1072 and Capromab pendetide, in patients with metastatic prostate cancer; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 123I MIP 1072
• Capromab pendetide (Capromab pendetide)

Snippet

Sponsor: Molecular Insight Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED